← SynDRA
MT-II
SynDRA canonical compound SYN1969163 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | MC1R | MC3R | MC4R | MC5R |
|---|
| Mechanism of action | melanocortin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- melanocortin receptor agonist
- MC4R AGONIST
- MC5R AGONIST
- MC1R AGONIST
- MC3R AGONIST
Cross-references
Synonyms
- Melanotan -Ii
- Melanotan (MT)-II
- Melatonan
- Melanotan II acetate salt
- CHEMBL430239
- L-Lysinamide, N-acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-, cyclic (2-7)-peptide
- (3S,6S,9R,12S,15S,23S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-3-yl)methyl)-15-((S)-2-acetamidohexanamido)-9-benzyl-6-(3-guanidinopropyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide
- C50H69N15O9
- Asp5
- Melanotan II acetate
- D-Phe7
- MTII
- MTII Melanotan-II
- Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2
- melanotan-II
- UPF5CJ93X7
- RefChem:925444
- DTXCID3075626
- MelanotanII
- Melanotan II?
- Ac-Nle-Cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
- UNII-UPF5CJ93X7
- MELANOTAN II [WHO-DD]
- ebi_340792
- GTPL1323
- orb1296657
- SCHEMBL1047531
- SCHEMBL29473785
- CHEBI:195326
- EX-A7394
- HY-P0267
- BDBM50027084
- BDBM50184359
- MFCD06795842
- AKOS015994654
- HS-2017
- NCGC00167281-01
- DA-55328
- FA109114
Look up MT-II in the interactive SynDRA portal →